| Xiaflex (collagenase clostridium histolyticum) / Asahi Kasei, SOBI, Endo |
NCT01518907: The Safety, Effectiveness, and Pharmacokinetics of AA4500 for the Treatment of Edematous Fibrosclerotic Panniculopathy (Commonly Known as Cellulite) |
|
|
| Completed | 1b | 99 | US | COLLAGENASE CLOSTRIDIUM HISTOLYTICUM, XIAFLEX, XIAPEX | Endo Pharmaceuticals | Edematous Fibrosclerotic Panniculopathy, Cellulite | 12/12 | 02/13 | | |
NCT00528931: A Pharmacokinetic Study of AA4500 (XIAFLEX™, Proposed Name) in Subjects With Dupuytren's Contracture |
|
|
| Completed | 1 | 16 | US | collagenase clostridium histolyticum, XIAFLEX®, AA4500 | Endo Pharmaceuticals | Dupuytren's Contracture | 12/07 | 03/08 | | |
NCT02889848: Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids) |
|
|
| Completed | 1 | 15 | US | Saline, EN3835, Collagenase clostridium histolyticum | Advance Biofactures Corporation | Fibroids, Uterine, Leiomyoma | 10/18 | 11/18 | | |
NCT03675685: Safety and Pharmacokinetics of a Single Dose of CCH (3.36 mg) in Subjects With EFP |
|
|
| Completed | 1 | 12 | US | CCH (collagenase clostridium histolyticum) | Endo Pharmaceuticals | Edematous Fibrosclerotic Panniculopathy | 11/18 | 11/18 | | |
NCT03898661: Collagenase Clostridium Histolyticum for Refractory Iatrogenic Esophageal Strictures |
|
|
| Terminated | 1 | 2 | Europe | Collagenase histiolyticum | University Hospital, Ghent | Stricture, Esophageal Stricture, Anastomotic, Collagenosis | 06/20 | 01/21 | | |
